Product
Supplier
Encyclopedia
Inquiry
17-AAG,98%,solid buy - large image1
17-AAG,98%,solid buy - image1

17-AAG,98%,solid

COA

Unit Price:

$700/G EXW

Get Latest Price
CAS No.:

75747-14-7

Packaging:

5g/bag

Price valid (until):

2026-08-16

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

Ginsenoside Rb1,Ginsenoside Rg1,Ginsenoside Re,Ginsenoside CK,Ginsenoside Rg2,Ginsenoside Rg5

  • Product Description

  • Seller Information

  • Description
    17-AAG (Tanespimycin) functions primarily as a potent, highly selective inhibitor of Heat Shock Protein 90 (Hsp90). Derived from the antibiotic geldanamycin, it binds specifically to the ATP-binding pocket of Hsp90, disrupting its molecular chaperone activity.
    Because cancer cells rely heavily on Hsp90 to keep unstable, mutated oncogenes folded correctly, 17-AAG effectively destabilizes the internal support system of a tumor.
    Its main biological functions and targeted applications include:
    1. Degradation of Oncogenic "Client Proteins"
    Hsp90 acts as a protective shield for many critical signaling proteins. When 17-AAG blocks Hsp90, these unprotected "client proteins" are misfolded and immediately marked for destruction via the ubiquitin-proteasome pathway. Key client proteins degraded by 17-AAG include:
    • Kinases & Receptors: HER2/ErbB2, Akt, Raf-1, v-Src, and Met.
    • Mutated Proteins: BCR-ABL (associated with leukemia) and mutated p53.
    • Transcription Factors: Hypoxia-inducible factor-1α (HIF-1α) and androgen/estrogen receptors.
    • Result: Simultaneously shutting down these survival pathways forces cancer cells to undergo cell cycle arrest and programmed death (apoptosis).
    2. Clinical Oncology Research (Anti-Tumor Agent)
    17-AAG was the first Hsp90 inhibitor to enter clinical trials and has been extensively studied for its multi-targeted anti-cancer properties:
    • Targeting Cancer Selectively: It binds to Hsp90 in cancer cells with a 100-fold higher affinity than in normal cells, because tumor-associated Hsp90 resides in an multi-protein complex that is highly sensitive to disruption.
    • Studied Indications: It has reached Phase II/III clinical trials for HER2-positive metastatic breast cancer and multiple myeloma, as well as trials for non-small cell lung cancer (NSCLC), melanoma, and chronic myeloid leukemia (CML).
    3. Reversing Drug Resistance in Laboratory Settings
    In biomedical research, 17-AAG is a vital tool for overcoming tumor resistance to standard therapies:
    • Overcoming Tyrosine Kinase Inhibitor (TKI) Resistance: For example, when chronic leukemia cells become resistant to imatinib due to a mutated BCR-ABL protein, 17-AAG bypasses this resistance by targeting the protein for destruction rather than just trying to block its active site.
      • Chemosensitization: It functions as a synergy booster when combined in vitro or in vivo with chemotherapeutics (like cisplatin, paclitaxel) or target biologicals (like trastuzumab), rendering stubborn cancer cells sensitive to treatment once more.


    Items Specifications
    melting point 201-203°C
    boiling point 797.8±60.0 °C
    color and appearance purple or dark solid solid
    storage conddition Keep in dark place,Sealed in dry,Store in freezer, under -20°C
    ECHEMI Editorial Reference
    17-AAG is a potent HSP90 inhibitor with an IC50 of 5 nM, having a 100-fold higher binding affinity for tumour cell derived HSP90 than normal cell derived HSP90.

    Certificates

    Basic Info
    Product Name:

    Tanespimycin

    Other Name:

    Geldanamycin,17-demethoxy-17-(2-propenylamino)-;2-Azabicyclo[16.3.1]docosane,geldanamycin deriv.;17-Demethoxy-17-(2-propenylamino)geldanamycin;CP 127374;17-(Allylamino)-17-demethoxygeldanamycin;NSC 330507;17-(Allylamino)geldanamycin;17-Demethoxy-17-allylaminogeldanamycin;17AAG;KOS 953;Tanespimycin;17-(Allylamino)-17-desmethylgeldanamycin;BMS 722782;17-N-Allylamino-17-demethoxygeldanamycin;17-Allylaminodemethoxygeldanamycin;A 8476

    CAS No.:

    75747-14-7

    Molecular Formula:

    C31H43N3O8

    InChIKeys:

    InChIKey=AYUNIORJHRXIBJ-TXHRRWQRSA-N

    Molecular Weight:

    585.69

    Exact Mass:

    585.69

    DSSTox ID:

    DTXSID5046352

    HScode:

    29419090

    Categories:

    Other Food Additives

    Characteristics
    PSA:

    166.28000

    XLogP3:

    3.95760

    Appearance:

    solid

    Density:

    1.2±0.1 g/cm3

    Melting Point:

    201-203°C

    Boiling Point:

    797.8°C at 760 mmHg

    Flash Point:

    >110°(230°F)

    Refractive Index:

    1.566

    Water Solubility:

    soluble in DMSO at 150 mg/mL; soluble in ethanol at 5 mg/mL. Very poorly soluble in water

    Storage Conditions:

    −20°C

    Hazard Identification

    Classification of the substance or mixture

    no data available

    GHS label elements, including precautionary statements

    Pictogram(s) no data available
    Signal word

    no data available

    Hazard statement(s)

    no data available

    Precautionary statement(s)
    Prevention

    no data available

    Response

    no data available

    Storage

    no data available

    Disposal

    no data available

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Ginsenoside Rb1,Ginsenoside Rg1,Ginsenoside Re,Ginsenoside CK,Ginsenoside Rg2,Ginsenoside Rg5

    Location:

    Chuangzhi valley,Chuangzhi Industrial Park ,Hanzhong Economic and Technological Dvelopment Zone,Hanzhong City, Shaanxi Province

    Total Annual Revenue:

    $2.5 million-$5 million

    Total Employees:

    51-100

    Year of Establishment:

    2019

  • Country Product Purchase Quantity Date Posted
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.